4//SEC Filing
Cara Therapeutics, Inc. 4
Accession 0001179110-17-005327
$TVRDCIK 0001346830operating
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 9:19 AM ET
Size
13.4 KB
Accession
0001179110-17-005327
Insider Transaction Report
Form 4
RHO Ventues VI LP
10% Owner
Transactions
- Purchase
Common Stock
2017-03-31$18.19/sh+500,000$9,095,700→ 3,568,057 total(indirect: See Footnote)
KAIROUZ HABIB
10% Owner
Transactions
- Purchase
Common Stock
2017-03-31$18.19/sh+500,000$9,095,700→ 3,568,057 total(indirect: See Footnote)
RUCH JOSHUA
10% Owner
Transactions
- Purchase
Common Stock
2017-03-31$18.19/sh+500,000$9,095,700→ 3,568,057 total(indirect: See Footnote)
Rho Capital Partners LLC
10% Owner
Transactions
- Purchase
Common Stock
2017-03-31$18.19/sh+500,000$9,095,700→ 3,568,057 total(indirect: See Footnote)
LESCHLY MARK
10% Owner
Transactions
- Purchase
Common Stock
2017-03-31$18.19/sh+500,000$9,095,700→ 3,568,057 total(indirect: See Footnote)
RMV VI, L.L.C.
10% Owner
Transactions
- Purchase
Common Stock
2017-03-31$18.19/sh+500,000$9,095,700→ 3,568,057 total(indirect: See Footnote)
Footnotes (1)
- [F1]These securities are owned directly by Rho Ventures VI, L.P. ("RV VI"). RMV VI, L.L.C. ("RMV") is the general partner of RV VI and Rho Capital Partners LLC ("RCP") is the managing member of RMV. Mark Leschly, Habib Kairouz and Joshua Ruch are managing members of RCP and exercise shared voting and investment power with respect to the shares owned by RV VI. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his or its respective pecuniary interest therein.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001346830
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 9:19 AM ET
- Size
- 13.4 KB